Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FC013
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,619
Award facts
- Contract value 100% obligated
- $67,619.13 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $67,619.13 to AmerisourceBergen Drug Corp for pharmaceutical products, with an ultimate completion date of January 13, 2026. This non-set-aside contract award was issued to the Pharmaceutical PV Division at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order represents a task order executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2026.
The contract supports DLA's medical supply chain operations by delivering pharmaceutical products and medical supplies across multiple therapeutic domains to military treatment facilities and other federal healthcare institutions. As a competitively awarded contract with firm fixed pricing, this delivery order demonstrates AmerisourceBergen's continued capability to fulfill federal medical procurement requirements. The company's broader IDC vehicle with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies, enabling efficient fulfillment of government pharmaceutical needs on a global scale to support Department of Defense healthcare programs.
Quick answers
Who was awarded contract SPE2DU26FC013?
SPE2DU26FC013 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DU26FC013 worth?
The government has obligated $67,619 on SPE2DU26FC013.
Is contract SPE2DU26FC013 an order under another contract?
Yes. SPE2DU26FC013 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FC013 competed?
The extent of competition for SPE2DU26FC013 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award